Rosmarinic Acid.

Lemon balm is standardised on rosmarinic acid, so the extract and the isolated phenol deliver the same principal compound. Pairing them stacks the same chemistry rather than adding an independent one.

Rosmarinic acid is the dominant polyphenol in Melissa officinalis leaf. Whole-leaf preparations supply it alongside the plant's other phenolic acids.

Rosemary is the plant the compound was named for and contains it alongside carnosic acid and carnosol. The phenolic diterpenes and rosmarinic acid work in different polarity phases of the same preparation.

Sage is a Lamiaceae species that accumulates rosmarinic acid as its main water-soluble phenolic. A sage extract therefore already contributes to the same phenolic pool.

Oregano leaf is one of the richest culinary sources of rosmarinic acid. Its phenolic fraction overlaps directly with an isolated rosmarinic acid ingredient.

Rosmarinic acid is an ester of caffeic acid with dihydroxyphenyllactic acid, and gut esterases and microbiota release caffeic acid from it. The two therefore share a metabolic pool and the same catechol redox behaviour.

When a catechol polyphenol quenches a radical it becomes a phenoxyl radical, which ascorbate can reduce back to the parent phenol. This recycling keeps the polyphenol pool in its active reduced form for longer.

Tocopherol works inside the lipid membrane while rosmarinic acid is water soluble and acts at the aqueous interface. Together they cover both sides of the boundary where lipid peroxidation propagates.

Both are phenolics cleared by intestinal and hepatic sulfation, glucuronidation and catechol O-methyltransferase. Loading several substrates at once occupies the same conjugating capacity.

The catechol groups on rosmarinic acid bind ferric iron tightly and form insoluble complexes in the gut lumen. Taken in the same dose window this lowers how much non-heme iron is available for uptake.

Ferrous sulfate provides free non-heme iron, which polyphenol catechols bind and precipitate before absorption. Separating the two by a couple of hours is the usual formulation answer.

Catechol phenolics coordinate copper as well as iron, and the resulting complex is not absorbed as free mineral. Dosing them together in one sitting reduces mineral availability.

Rosmarinic acid carries two catechol groups that donate hydrogen atoms to radicals directly, which is a different job from the thiol-based recycling glutathione performs. In cell and animal models the two are usually reported together, with glutathione pools holding up better when a catechol polyphenol is present. That is a marker relationship measured in tissue, not a demonstrated outcome in people.

NAC supplies cysteine for glutathione synthesis, which sits on the thiol side of redox handling. Rosmarinic acid works on the phenolic side, quenching radicals without needing sulfur. Formulators pair them to cover both arms; the pairing itself has not been isolated in a human trial.

Alpha-lipoic acid cycles between oxidised and reduced forms and participates in regenerating other antioxidants. Rosmarinic acid is water-soluble and stays largely in the aqueous compartment, so the two occupy different physical space in a formula. Read the pairing as mechanistic rather than clinical.

A cell study in microglia reported that polyphenols, rosmarinic acid among them, suppressed reactive oxygen species produced when intracellular zinc ran low. That is a cultured-cell observation about a marker, not evidence of an effect in a person. Zinc status and polyphenol handling interact in more than one direction, so the pairing is worth stating and not worth overstating.

Both are polyphenols cleared largely by glucuronidation and sulfation in the gut wall and liver. Combining them broadens the range of radical species covered, and it also loads the same conjugation enzymes, so neither one reaches the blood unchanged in any large amount. Formulas that stack polyphenols should count that shared clearance route.

Curcuminoids are lipophilic and rosmarinic acid is water-soluble, so a blend covers both phases of a capsule or a beverage. Both are extensively conjugated before they reach circulation. The combination is a formulation convention with mechanistic logic behind it rather than a tested pair.

Rosmarinic acid is heavily glucuronidated and sulfated in the intestinal wall, which is the main reason free plasma levels stay low. Piperine slows those same conjugation enzymes, which is why it appears in so many polyphenol formulas. The general mechanism is well described; the specific effect on rosmarinic acid pharmacokinetics has not been isolated.

Most ingested rosmarinic acid escapes absorption in the small intestine and reaches the colon intact, where bacterial esterases split it into caffeic acid and dihydroxyphenyllactic acid, then further into smaller phenolic acids. Those metabolites, not the parent molecule, account for much of what shows up in urine. Which bacteria are present therefore shapes what a person actually absorbs.

Inulin is fermented in the colon and shifts the composition of the microbial community. Since colonic bacteria are what convert rosmarinic acid into its absorbable metabolites, a prebiotic can plausibly change that conversion. The link is inferred from two established steps, not measured as a pair.

L-theanine is a common pairing in calm-focus blends, and rosmarinic acid is the marker compound of lemon balm preparations used the same way. Someone taking both alongside other relaxing ingredients should count the total sedative load rather than each item separately. No trial has tested the two together.

Chamomile and rosmarinic-acid-bearing Lamiaceae herbs have been combined in infusions for a long time, and chamomile itself contains apigenin glycosides in the same phenolic family. The pairing is convention supported by shared chemistry. It has not been separated out in a controlled study.

Passionflower appears in the same evening formulas as lemon balm extracts standardised to rosmarinic acid. Anyone stacking several calming botanicals should account for the combined effect on alertness. The additive direction is the flag here, not a benefit claim.

Luteolin glycosides sit alongside rosmarinic acid in rosemary, sage and lemon balm, so a whole-leaf extract delivers both whether or not the label says so. They are chemically distinct, a flavone against a phenolic ester, and cover overlapping radical species. A standardised single-compound preparation will not carry the flavone.

Apigenin is present in several of the herbs from which rosmarinic acid is extracted. Both are glucuronidated before entering circulation, so they compete for the same conjugating capacity at high intakes. The pairing is native to the plant rather than engineered.

Phospholipid complexes are a standard way to carry poorly absorbed plant phenolics across the intestinal wall. Lecithin supplies the phosphatidylcholine that forms the complex. The approach is well described for the polyphenol class; a rosmarinic acid specific pharmacokinetic comparison is not something the candidate literature settles.

Astaxanthin sits inside membranes; rosmarinic acid stays in the watery compartment. A blend therefore covers two different places where radicals form. This is a chemistry argument, not a measured combination effect.